New Drug Evaluations are concise, structured reviews of new drugs recently launched within the NHS. The aim of this publication is to evaluate the efficacy, safety and potential place in therapy of Clascoterone cream a first-in-class androgen receptor inhibitor indicated for the topical treatment of acne vulgaris in patients 12 years of age and older.
A Formulary Assessment Tool is also available on this topic. Formulary Assessment Tools are pre-populated templates with space for local adaptation, to reduce duplication and support decision-making